4 research outputs found
A personalized intervention to prevent depression in primary care: cost-effectiveness study nested into a clustered randomized trial
Abstract
Background: Depression is viewed as a major and increasing public health issue, as it causes high distress in the
people experiencing it and considerable financial costs to society. Efforts are being made to reduce this burden
by preventing depression. A critical component of this strategy is the ability to assess the individual level and
profile of risk for the development of major depression. This paper presents the cost-effectiveness of a personalized
intervention based on the risk of developing depression carried out in primary care, compared with usual care.
Methods: Cost-effectiveness analyses are nested within a multicentre, clustered, randomized controlled trial of a
personalized intervention to prevent depression. The study was carried out in 70 primary care centres from seven
cities in Spain. Two general practitioners (GPs) were randomly sampled from those prepared to participate in each
centre (i.e. 140 GPs), and 3326 participants consented and were eligible to participate. The intervention included
the GP communicating to the patient his/her individual risk for depression and personal risk factors and the
construction by both GPs and patients of a psychosocial programme tailored to prevent depression. In addition,
GPs carried out measures to activate and empower the patients, who also received a leaflet about preventing
depression. GPs were trained in a 10- to 15-h workshop. Costs were measured from a societal and National Health
care perspective. Qualityadjustedlife years were assessed using the EuroQOL five dimensions questionnaire.
The time horizon was 18 months.This work was supported by grants from the Spanish Ministry of Health, the
Institute of Health Carlos III (ISCIII) and the European Regional Development
Fund (ERDF) âA way to build Europeâ(grant references PS09/02272, PS09/02147,
PS09/01095, PS09/00849 and PS09/00461); the Andalusian Council of Health
(grant reference PI-0569-2010); the Spanish Network of Primary Care Research
âredIAPPâ (RD06/0018, RD12/0005/0001); the âAragĂłn groupâ (RD06/0018/0020,
RD12/0005/0006); the âBizkaya groupâ (RD06/0018/0018, RD12/0005/0010); the
Castilla-LeĂłn Group (RD06/0018/0027); the Mental Health (SJD) Barcelona Group
(RD06/0018/0017, RD12/0005/0008); and the Mental-Health, Services and
Primary Care (SAMSERAP) MĂĄlagaGroup (RD06/0018/0039, RD12/0005/0005)
A personalized intervention to prevent depression in primary care: cost-effectiveness study nested into a clustered randomized trial.
Depression is viewed as a major and increasing public health issue, as it causes high distress in the people experiencing it and considerable financial costs to society. Efforts are being made to reduce this burden by preventing depression. A critical component of this strategy is the ability to assess the individual level and profile of risk for the development of major depression. This paper presents the cost-effectiveness of a personalized intervention based on the risk of developing depression carried out in primary care, compared with usual care. Cost-effectiveness analyses are nested within a multicentre, clustered, randomized controlled trial of a personalized intervention to prevent depression. The study was carried out in 70 primary care centres from seven cities in Spain. Two general practitioners (GPs) were randomly sampled from those prepared to participate in each centre (i.e. 140 GPs), and 3326 participants consented and were eligible to participate. The intervention included the GP communicating to the patient his/her individual risk for depression and personal risk factors and the construction by both GPs and patients of a psychosocial programme tailored to prevent depression. In addition, GPs carried out measures to activate and empower the patients, who also received a leaflet about preventing depression. GPs were trained in a 10- to 15-h workshop. Costs were measured from a societal and National Health care perspective. Qualityadjustedlife years were assessed using the EuroQOL five dimensions questionnaire. The time horizon was 18 months. With a willingness-to-pay threshold of âŹ10,000 (ÂŁ8568) the probability of cost-effectiveness oscillated from 83% (societal perspective) to 89% (health perspective). If the threshold was increased to âŹ30,000 (ÂŁ25,704), the probability of being considered cost-effective was 94% (societal perspective) and 96%, respectively (health perspective). The sensitivity analysis confirmed these results. Compared with usual care, an intervention based on personal predictors of risk of depression implemented by GPs is a cost-effective strategy to prevent depression. This type of personalized intervention in primary care should be further developed and evaluated. ClinicalTrials.gov, NCT01151982. Registered on June 29, 2010
Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation
Altres ajuts: Alliance Bristol-Myers Squibb/Pfizer.Background: This study assessed the sociodemographic, functional, and clinical determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation (NVAF) attended in the internal medicine setting. Methods: A multicenter, cross-sectional study was conducted in NVAF patients who attended internal medicine departments for either a routine visit (outpatients) or hospitalization (inpatients). Results: A total of 961 patients were evaluated. Their antithrombotic management included: no treatment (4.7%), vitamin K antagonists (VKAs) (59.6%), direct oral anticoagulants (DOACs) (21.6%), antiplatelets (6.6%), and antiplatelets plus anticoagulants (7.5%). Permanent NVAF and congestive heart failure were associated with preferential use of oral anticoagulation over antiplatelets, while intermediate-to high-mortality risk according to the PROFUND index was associated with a higher likelihood of using antiplatelet therapy instead of oral anticoagulation. Longer disease duration and institutionalization were identified as determinants of VKA use over DOACs. Female gender, higher education, and having suffered a stroke determined a preferential use of DOACs. Conclusions: This real-world study showed that most elderly NVAF patients received oral anticoagulation, mainly VKAs, while DOACs remained underused. Antiplatelets were still offered to a proportion of patients. Longer duration of NVAF and institutionalization were identified as determinants of VKA use over DOACs. A poor prognosis according to the PROFUND index was identified as a factor preventing the use of oral anticoagulation
Evaluation of a quality improvement intervention to reduce anastomotic leak following right colectomy (EAGLE): pragmatic, batched stepped-wedge, cluster-randomized trial in 64 countries
Background
Anastomotic leak affects 8 per cent of patients after right colectomy with a 10-fold increased risk of postoperative death. The EAGLE study aimed to develop and test whether an international, standardized quality improvement intervention could reduce anastomotic leaks.
Methods
The internationally intended protocol, iteratively co-developed by a multistage Delphi process, comprised an online educational module introducing risk stratification, an intraoperative checklist, and harmonized surgical techniques. Clusters (hospital teams) were randomized to one of three arms with varied sequences of intervention/data collection by a derived stepped-wedge batch design (at least 18 hospital teams per batch). Patients were blinded to the study allocation. Low- and middle-income country enrolment was encouraged. The primary outcome (assessed by intention to treat) was anastomotic leak rate, and subgroup analyses by module completion (at least 80 per cent of surgeons, high engagement; less than 50 per cent, low engagement) were preplanned.
Results
A total 355 hospital teams registered, with 332 from 64 countries (39.2 per cent low and middle income) included in the final analysis. The online modules were completed by half of the surgeons (2143 of 4411). The primary analysis included 3039 of the 3268 patients recruited (206 patients had no anastomosis and 23 were lost to follow-up), with anastomotic leaks arising before and after the intervention in 10.1 and 9.6 per cent respectively (adjusted OR 0.87, 95 per cent c.i. 0.59 to 1.30; P = 0.498). The proportion of surgeons completing the educational modules was an influence: the leak rate decreased from 12.2 per cent (61 of 500) before intervention to 5.1 per cent (24 of 473) after intervention in high-engagement centres (adjusted OR 0.36, 0.20 to 0.64; P < 0.001), but this was not observed in low-engagement hospitals (8.3 per cent (59 of 714) and 13.8 per cent (61 of 443) respectively; adjusted OR 2.09, 1.31 to 3.31).
Conclusion
Completion of globally available digital training by engaged teams can alter anastomotic leak rates. Registration number: NCT04270721 (http://www.clinicaltrials.gov)